Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$253.3 - $285.89 $1.27 Million - $1.43 Million
5,000 New
5,000 $1.29 Million
Q3 2022

Nov 02, 2022

BUY
$194.69 - $268.46 $4.89 Million - $6.74 Million
25,100 New
25,100 $6.7 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Clear Street LLC Portfolio

Follow Clear Street LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street LLC with notifications on news.